(r) cerus corporation:1188061 [26-000202]
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00071
- Awardee
-
Cerus Corporation UEI KJJQRRLY2FL5
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,336
Award facts
- Contract value 100% obligated
- $225,336.00 Current and potential, with all options
- Completion date 95% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Concord, CA 94520, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,800 | |
| Original award | $223,536 |
About this award
Cerus Corporation received a funding-only modification to an existing firm fixed-price purchase order from the Office of Logistics and Acquisition Operations, a civilian agency within the federal government. This modification, awarded on March 9, 2026, addresses a tariff increase and establishes a ceiling value of $225,336. The contract is scheduled for ultimate completion by November 8, 2026, with performance taking place at Cerus's headquarters in Concord, California. No set-aside designation was used for this award.
Cerus Corporation is a biomedical products manufacturer specializing in blood safety technologies, particularly its proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood components. The company has established itself as a critical supplier to federal healthcare agencies, including the Defense Health Agency and the National Institutes of Health Clinical Center, providing INTERCEPT processing sets, storage containers, and maintenance services for military and federal medical facilities. This funding modification reflects the company's ongoing role as a sole-source provider of innovative pathogen reduction solutions for blood transfusion safety across the federal healthcare system.
Quick answers
Who was awarded contract 75N98026P00071?
75N98026P00071 was awarded to Cerus Corporation by Office of Logisitics and Acquisition Operations (National Institutes of Health) on March 9, 2026.
How much is contract 75N98026P00071 worth?
The government has obligated $225,336 on 75N98026P00071.
Was contract 75N98026P00071 competed?
The extent of competition for 75N98026P00071 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award